BACKGROUND: Tai chi, also called taiji or tai chi chuan, is a form of mind-body exercise that originated from China. It combines Chinese martial arts and meditative movements that promote balance and healing of the mind and body, involving a series of slowly performed, dance-like postures that flow into one another. As it comprises mental concentration, physical balance, muscle relaxation, and relaxed breathing, tai chi shows great potential for becoming widely integrated into the prevention and rehabilitation of a number of medical and psychological conditions. PURPOSE: A growing body of clinical research has begun to evaluate the efficacy of tai chi as a therapy for a variety of health issues. A systematic review and meta-analysis were carried out on randomized controlled trials (RCTs) and quasi-experimental (Q-E) trials that studied the effects of tai chi on psychological well-being. METHOD: Drawn from English and Chinese databases, 37 RCTs and 5 Q-E studies published up to May 31, 2013 were included in the systematic review. The methodological quality of the RCTs was evaluated based on the following criteria: adequate sequence generation, allocation concealment, blinding, completeness of outcome data, selective reporting, and other potential biases. Statistical analyses were performed using Review Manager version 5.0. RESULTS: The studies in this review demonstrated that tai chi interventions have beneficial effects for various populations on a range of psychological well-being measures, including depression, anxiety, general stress management, and exercise self-efficacy. Meta-analysis was performed on three RCTs that used depression as an outcome measure (ES=-5.97; 95% CI -7.06 to -4.87), with I2=0%. CONCLUSION: In spite of the positive outcomes, the studies to date generally had significant methodological limitations. More RCTs with rigorous research design are needed to establish the efficacy of tai chi in improving psychological well-being and its potential to be used in interventions for populations with various clinical conditions.
BACKGROUND: Tai chi, also called taiji or tai chi chuan, is a form of mind-body exercise that originated from China. It combines Chinese martial arts and meditative movements that promote balance and healing of the mind and body, involving a series of slowly performed, dance-like postures that flow into one another. As it comprises mental concentration, physical balance, muscle relaxation, and relaxed breathing, tai chi shows great potential for becoming widely integrated into the prevention and rehabilitation of a number of medical and psychological conditions. PURPOSE: A growing body of clinical research has begun to evaluate the efficacy of tai chi as a therapy for a variety of health issues. A systematic review and meta-analysis were carried out on randomized controlled trials (RCTs) and quasi-experimental (Q-E) trials that studied the effects of tai chi on psychological well-being. METHOD: Drawn from English and Chinese databases, 37 RCTs and 5 Q-E studies published up to May 31, 2013 were included in the systematic review. The methodological quality of the RCTs was evaluated based on the following criteria: adequate sequence generation, allocation concealment, blinding, completeness of outcome data, selective reporting, and other potential biases. Statistical analyses were performed using Review Manager version 5.0. RESULTS: The studies in this review demonstrated that tai chi interventions have beneficial effects for various populations on a range of psychological well-being measures, including depression, anxiety, general stress management, and exercise self-efficacy. Meta-analysis was performed on three RCTs that used depression as an outcome measure (ES=-5.97; 95% CI -7.06 to -4.87), with I2=0%. CONCLUSION: In spite of the positive outcomes, the studies to date generally had significant methodological limitations. More RCTs with rigorous research design are needed to establish the efficacy of tai chi in improving psychological well-being and its potential to be used in interventions for populations with various clinical conditions.
Authors: Nancy L McCain; D Patricia Gray; R K Elswick; Jolynne W Robins; Inez Tuck; Jeanne M Walter; Sarah M Rausch; Jessica McKinney Ketchum Journal: J Consult Clin Psychol Date: 2008-06
Authors: Gurjeet S Birdee; Peter M Wayne; Roger B Davis; Russell S Phillips; Gloria Y Yeh Journal: J Altern Complement Med Date: 2009-09 Impact factor: 2.579
Authors: Chenchen Wang; Christopher H Schmid; Ramel Rones; Robert Kalish; Janeth Yinh; Don L Goldenberg; Yoojin Lee; Timothy McAlindon Journal: N Engl J Med Date: 2010-08-19 Impact factor: 91.245
Authors: Steven L Wolf; Richard W Sattin; Michael Kutner; Michael O'Grady; Arlene I Greenspan; Robert J Gregor Journal: J Am Geriatr Soc Date: 2003-12 Impact factor: 5.562
Authors: Laura S Redwine; Ming Tsuang; Anna Rusiewicz; Ines Pandzic; Stephanie Cammarata; Thomas Rutledge; Suzi Hong; Sarah Linke; Paul J Mills Journal: J Altern Complement Med Date: 2012-07-30 Impact factor: 2.579
Authors: Chong-Wen Wang; Cecilia Lai Wan Chan; Rainbow T H Ho; Hector W H Tsang; Celia Hoi Yan Chan; Siu-Man Ng Journal: Evid Based Complement Alternat Med Date: 2013-05-20 Impact factor: 2.629
Authors: Melony E Sorbero; Kerry Reynolds; Benjamin Colaiaco; Susan L Lovejoy; Coreen Farris; Christine Anne Vaughan; Jennifer Sloan; Ryan Kandrack; Eric Apaydin; Patricia M Herman Journal: Rand Health Q Date: 2016-05-09
Authors: On-Yee Lo; Lisa A Conboy; Alexandra Rukhadze; Caroline Georgetti; Margaret M Gagnon; Brad Manor; Margie E Lachman; Lewis A Lipsitz; Peter M Wayne Journal: Gerontologist Date: 2020-05-15
Authors: Augustine C Lee; Jeffrey B Driban; Lori Lyn Price; William F Harvey; Angie Mae Rodday; Chenchen Wang Journal: J Pain Date: 2017-05-10 Impact factor: 5.820
Authors: Lisa Conboy; Julie Krol; Jose Tomas; Gloria Y Yeh; Peter Wayne; Elana Salmoirago-Blotcher Journal: BMJ Support Palliat Care Date: 2019-04-04 Impact factor: 3.568
Authors: Karen J Sherman; Robert D Wellman; Rene J Hawkes; Elizabeth A Phelan; Tamsin Lee; Judith A Turner Journal: J Altern Complement Med Date: 2020-02-03 Impact factor: 2.579